In contrast to thermal ablation such as RFA and MWA, which relies on a temperature typically above 60  ̊C, local hyperthermia (42.5  ̊C for 20 min) with anti-CTLA-4 was also shown to enhance the anti-tumor response (279). The gene discussed is CTLA4; the disease is neoplasm.